Lymphangiectasis, Intestinal
Lymphangioma
Osteolysis, Essential
Lymphangioleiomyomatosis
Encyclopedias as Topic
Fibercolonoscopy for the diagnosis of granulomatous colitis. (1/42)
In order to clarify the significance of fibercolonoscopy in diagnosis of granulomatous colitis, the pathological, radiological, endoscopic and clinical differences between granulomatous colitis and ulcerative colitis were investigated on 12 cases of granulomatous colitis and 23 cases of ulcerative colitis, which underwent colonic resections between 1954 and 1973. The comparative studies have revealed considerable differences in their characteristic features besides the overlapping spectrum. As a consequence of assessments made of the various diagnostic techniques as to usefulness in differential diagnosis between the two colitis conditions, it was noted that fibercolonoscopy and biopsy under direct vision, when applied in conjunction with the conventional procedures, readily facilitate the differential diagnosis without any surgical intervention in all aspects, excepting the depth of inflammatory involvement and the presence of lymphangiectasia. However, the depth of the inflammed lesion as well as lymphangiectasia can also be estimated indirectly. Therefore, it seems that it is possible to make the differential diagnosis between the two colitis conditions even prior to colectomy, with the exception of atypical forms which represent overlapping findings. (+info)Lymphangiectatic fibrolipomatous polyp of the palatine tonsil. (2/42)
A rare benign polypoid tumor of the right palatine tonsil is described in a 23 year old male. It contained dilated lymphatic channels surrounded by fibrous tissue and foci of mature fat. The features of this lesion add support to the hypothesis that benign tumors of tonsil may be hamartomas of tonsil rather than true neoplasms. The differential diagnosis of polypoid lesions of the tonsil is discussed. (+info)Treatment of symptomatic primary chylous disorders. (3/42)
PURPOSE: Primary chylous disorders (PCDs) are rare. Rupture of dilated lymph vessels (lymphangiectasia) may result in chylous ascites, chylothorax, or leakage of chyle through chylocutanous fistulas in the lower limbs or genitalia. Chyle may reflux through incompetent lymphatics, causing lymphedema. To assess the efficacy of surgical treatment, we reviewed our experience. METHODS: The clinical data of 35 patients with PCDs treated between January 1, 1976, and August 31, 2000, were reviewed retrospectively. RESULTS: Fifteen men and 20 women (mean age, 29 years; range, 1 day-81 years) presented with PCDs. Sixteen (46%) patients had chylous ascites, and 19 (54%) had chylothorax (20 patients), and of these, 10 (29%) had both. In 16 patients, reflux of chyle into the pelvic or lower limb lymphatics caused lymphedema (14, 88%) or lymphatic leak through cutaneous fistulae (11, 69%). Presenting symptoms included lower-limb edema (19, 54%), dyspnea (17, 49%), scrotal or labial edema (15, 43%), or abdominal distention (13, 37%). Primary lymphangiectasia presented alone in 23 patients (66%), and it was associated with clinical syndromes or additional pathologic findings in 12 (yellow nail syndrome in 4, lymphangiomyomatosis in 3, unknown in 3, Prasad syndrome (hypogammaglobulinemia, lymphadenopathy, and pulmonary insufficiency) in 1, and thoracic duct cyst in 1). Twenty-one (60%) patients underwent 26 surgical procedures. Preoperative imaging included computed tomography scan in 15 patients, magnetic resonance imaging in 3, lymphoscintigraphy in 12, and lymphangiography in 14. Fifteen patients underwent 18 procedures for chylous ascites or pelvic reflux. Ten (56%) procedures were resection of retroperitoneal/mesenteric lymphatics with or without sclerotherapy of lymphatics, 4 (22%) were lymphovenous anastomoses or grafts, 3 (17%) were peritoneovenous shunts, and 1 (6%) patient had a hysterectomy. Six patients underwent eight procedures for chylothorax, including thoracotomy with decortication and pleurodesis (4 procedures), thoracoscopic decortication (1 patient), ligation of thoracic duct (2 procedures), and resection of thoracic duct cyst (1 patient). Postoperative mean follow-up was 54 months (range, 0.3-276). Early complications included wound infections in 3 patients, elevated liver enzymes in 1, and peritoneovenous shunt occlusion with innominate vein occlusion in 1. All patients improved initially, but four (19%) had recurrence of symptoms at a mean of 25 months (range, 1-43). Three patients had postoperative lymphoscintigraphy confirming improved lymphatic transport and diminished reflux. One patient died 12 years postoperatively, from causes unrelated to PCD. CONCLUSIONS: More than half of the patients with PCDs require surgical treatment, and surgery should be considered in patients with significant symptoms of PCD. Lymphangiography is recommended to determine anatomy and the site of the lymphatic leak, especially if lymphovenous grafting is planned. All patients had initial benefit postoperatively and two thirds of patients demonstrated durable clinical improvement after surgical treatment. (+info)The lungs in lymphangiomyomatosis and in tuberous sclerosis. (4/42)
Two cases of pulmonary lymphangiomyomatosis (PL) are described and 33 other cases from the literature are reviewed. These are compared with one case of tuberous sclerosis with pulmonary involvement (PTS) and 32 other cases from the literature. There are no differences in lung function between these two conditions, both of which show airways obstruction associated with diffuse radiological lung changes. There are, however, both clinical and radiological differences and also differences in the distribution of the lesions and the histological location of the excessive smooth muscle; these indicate that PL and PTS are probably different entities and not polar forms of one condition. Finally, the strictly female incidence of PL suggests a sex-linked disorder, and it is postulated that this may be related to congenital pulmonary lymphangiectases. (+info)A case of primary hyperparathyroidism due to an oxyphil cell adenoma. (5/42)
A 59-year-old woman with primary hyperparathyroidism was found to have a parathyroid adenoma behind the left clavicle. Preoperatively, it appeared as a hypoechoic mass on ultrasonography, as a hot nodule on thallium scintigraphy, and as a high signal on T2-weighted magnetic resonance imaging. Histological, immunohistochemical and ultrastructural studies of the surgically resected tumor revealed a parathyroid adenoma composed mainly of oxyphil cells with production of a parathyroid hormone. Moreover, a multilocular lesion of lymphangiectasia was contained. Hypercalcemia was alleviated postoperatively. These observations corroborated a functioning parathyroid oxyphil cell adenoma. This is the first case report of functioning oxyphil cell adenoma of the parathyroid gland with lymphangiectasia in Japan. (+info)Acquired lymphangiectasis after breast conservation treatment for breast cancer: report of a case. (6/42)
Acquired lymphangiectasis is a dilatation of lymphatic vessels that can result as a complication of surgical intervention and radiation therapy for malignancy. Acquired lymphangiectasis shares clinical and histological features with the congenital lesion, lymphangioma circumscriptum. Diagnosis and treatment of these vesiculobullous lesions is important because they may be associated with pain, chronic drainage, and cellulitis. We describe patient who had these lesions after treatment for cancer. Although a number of treatment options are available, we have found cryosurgery and electrocautery to be particularly effective. (+info)Primary pulmonary lymphangiectasia in infancy and childhood. (7/42)
Primary pulmonary lymphangiectasia (PPL) is a rare disorder of unknown aetiology characterised by dilatation of the pulmonary lymphatics. PPL is widely reported to have a poor prognosis in the neonatal period and little is known about the clinical features of patients who survive the newborn period. The current authors report the outcome in nine patients diagnosed in infancy with PPL over a 15-yr period at a single university-based hospital clinic and followed for a median of 6 yrs. Although all of the patients initially experienced respiratory distress, respiratory symptoms improved in most patients after infancy and were notably better by the age of 6 yrs. Many patients had poor weight gain in the first years of life, which eventually improved. Radiological scans showed progressive resolution of neonatal infiltrates, but were characterised by hyperinflation and increased interstitial markings in older children. Most patients had evidence of bronchitis and grew pathogenic organisms from quantitative bronchoalveolar lavage culture. Pulmonary function tests showed predominantly obstructive disease that did not deteriorate over time. In conclusion, these results suggest that primary pulmonary lymphangiectasia does not have as dismal a prognosis as previously described and symptoms and clinical findings improve after the first year of life. (+info)Hypoplasia of the small pulmonary arteries in hypoplastic left heart syndrome with restrictive atrial septal defect. (8/42)
BACKGROUND: Restrictive atrial septal defect (ASD) (including intact atrial septum [IAS]) has been reported to be a risk factor that negatively impacts survival in hypoplastic left heart syndrome (HLHS). Although lymphangiectasia and "arterialization" of the veins of the lung in HLHS with restrictive ASD have been reported, they cannot fully explain the high mortality. We have introduced a new method of evaluating the development of the pulmonary vasculature in histological sections and used it to assess patients' lungs. We tested the hypothesis that the small pulmonary arteries (SPA), which are pulmonary arteries in a histological section whose radii are approximately 25 microm to 250 microm, in HLHS with restrictive ASD are hypoplastic, but that the alveoli are not, to elucidate the mechanism underlying the poor outcome of these patients. METHODS AND RESULTS: Fourteen HLHS patients between 1 day and 40 days of age were studied. In 8 cases, the ASD was restrictive [R(+) group], and in the other 6 cases it was not [R(-) group]. Specimens from 12 autopsies of cases with no congenital heart or pulmonary disease were examined as a control group (C group). As a novel histological parameter, we assessed the size of SPA in relation to the size of accompanying bronchioles to identify SPA underdevelopment. To evaluate the development of alveoli and interstitial tissue, radial alveolar counts (RAC), which reflect alveolar maturity and complexity, were also performed. Statistical comparisons between groups were made by analysis of covariance with age as a covariant factor. When the radius of the accompanying bronchiole was 100 microm, the radius of the SPA was 34.0+/-10.8 microm in the R(+) group, and significantly lower than the 46.6+/-8.5 microm in R(-) group (P=0.0022) and 70.5+/-8.4 microm in the C group (P<0.0001). The RAC was in 3.5+/-0.9 in the R(+) group, 3.4+/-0.6 in the R(-) group, and 3.7+/-0.9 in the C group (no significant differences between groups). CONCLUSIONS: The SPA in HLHS with restrictive ASD were underdeveloped compared with the SPA in HLHS with nonrestrictive ASD and the controls, but their alveoli were not hypoplastic. Based on these results, it is speculated that SPA hypoplasia may be responsible for the poor outcome of HLHS with restrictive ASD. (+info)Lymphangiectasis is a medical condition characterized by the dilation and abnormal expansion of lymphatic vessels, which are responsible for transporting lymph fluid throughout the body. These dilated lymphatic vessels can be found in various tissues and organs, including the intestines, lungs, or other parts of the body.
In the case of intestinal lymphangiectasis (also known as Waldmann's disease), the lymphatic vessels in the small intestine become enlarged, leading to impaired absorption of nutrients and lymph fluid. This can result in protein-losing enteropathy, malnutrition, diarrhea, and edema (swelling) due to the loss of proteins and lymphatic fluids into the gastrointestinal tract.
Pulmonary lymphangiectasis is a rare congenital disorder where the lymphatic vessels in the lungs are abnormally developed and dilated, causing respiratory distress, recurrent lung infections, and chylous effusions (accumulation of milky lymph fluid in the pleural space surrounding the lungs).
Treatment for lymphangiectasis depends on the underlying cause and severity of the condition. It may involve dietary modifications, medications to manage symptoms, or surgical interventions in some cases.
Intestinal lymphangiectasis is a rare condition characterized by the dilation and dysfunction of the lacteals (lymphatic vessels) within the intestinal villi. This results in the leakage of lymphatic fluid into the gastrointestinal lumen, leading to chronic protein loss, malabsorption of nutrients, and various other complications.
The condition can be primary (congenital), which is usually caused by genetic mutations affecting lymphatic development, or secondary, resulting from acquired conditions that obstruct or damage the intestinal lymphatics. Secondary intestinal lymphangiectasis may occur due to various causes such as abdominal surgeries, radiation therapy, inflammatory bowel disease, or tumors compressing the lymphatic vessels.
Symptoms of intestinal lymphangiectasis include diarrhea, steatorrhea (fatty stools), weight loss, edema (swelling), and hypoproteinemia (low protein levels in the blood). The diagnosis typically involves imaging techniques like lymphangiography or magnetic resonance imaging (MRI) to visualize the dilated lymphatic vessels. Treatment often focuses on dietary modifications, such as a low-fat, high-protein, and medium-chain triglyceride diet, along with managing any underlying conditions contributing to the development of the disease. In some cases, medications or surgical interventions may be necessary to alleviate symptoms and improve quality of life.
Lung diseases refer to a broad category of disorders that affect the lungs and other structures within the respiratory system. These diseases can impair lung function, leading to symptoms such as coughing, shortness of breath, chest pain, and wheezing. They can be categorized into several types based on the underlying cause and nature of the disease process. Some common examples include:
1. Obstructive lung diseases: These are characterized by narrowing or blockage of the airways, making it difficult to breathe out. Examples include chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis, and cystic fibrosis.
2. Restrictive lung diseases: These involve stiffening or scarring of the lungs, which reduces their ability to expand and take in air. Examples include idiopathic pulmonary fibrosis, sarcoidosis, and asbestosis.
3. Infectious lung diseases: These are caused by bacteria, viruses, fungi, or parasites that infect the lungs. Examples include pneumonia, tuberculosis, and influenza.
4. Vascular lung diseases: These affect the blood vessels in the lungs, impairing oxygen exchange. Examples include pulmonary embolism, pulmonary hypertension, and chronic thromboembolic pulmonary hypertension (CTEPH).
5. Neoplastic lung diseases: These involve abnormal growth of cells within the lungs, leading to cancer. Examples include small cell lung cancer, non-small cell lung cancer, and mesothelioma.
6. Other lung diseases: These include interstitial lung diseases, pleural effusions, and rare disorders such as pulmonary alveolar proteinosis and lymphangioleiomyomatosis (LAM).
It is important to note that this list is not exhaustive, and there are many other conditions that can affect the lungs. Proper diagnosis and treatment of lung diseases require consultation with a healthcare professional, such as a pulmonologist or respiratory therapist.
Lymphangioma is a benign (noncancerous) tumor or malformation that occurs due to the abnormal development of the lymphatic system, a part of the immune system that helps fight infection and eliminate waste products. Lymphangiomas are typically composed of dilated lymphatic vessels filled with clear fluid called lymph. These masses can occur in various parts of the body but are most commonly found in the head, neck, and axilla (armpit) regions.
There are three main types of lymphangiomas:
1. Capillary lymphangioma: Also known as "lymphangiectasia" or "lymphangiomatosis," this is the most superficial and least aggressive type, often presenting as small vesicles or blisters on the skin.
2. Cavernous lymphangioma: This type consists of larger, more dilated lymphatic spaces and can involve deeper tissues. It usually appears as a soft, compressible mass beneath the skin.
3. Cystic hygroma: A subtype of cavernous lymphangioma, cystic hygromas are typically found in the neck or axilla regions and present as large, fluid-filled sacs or cysts.
Lymphangiomas can cause various symptoms depending on their size and location, including swelling, pain, infection, difficulty swallowing, or breathing problems if they compress vital structures such as airways or blood vessels. Treatment options may include surgical excision, sclerotherapy (injection of a substance to shrink the lesion), or observation, depending on the individual case and patient's preferences.
Essential osteolysis is not a well-defined medical condition with a single, widely accepted medical definition. The term "osteolysis" generally refers to the loss or resorption of bone tissue. In essential osteolysis, this process occurs without an underlying cause that can be easily identified, such as a tumor, infection, or other disease.
Some sources describe essential osteolysis as a condition characterized by progressive bone loss that occurs spontaneously and symmetrically, typically affecting the small bones of the hands and feet. The exact cause of this form of osteolysis is not known, but it is thought to be related to an abnormal immune response or genetic factors.
It's important to note that essential osteolysis is a rare condition, and its symptoms and progression can vary significantly from person to person. If you have concerns about osteolysis or any other medical condition, it's best to consult with a healthcare professional for an accurate diagnosis and treatment plan.
Chylothorax is a medical condition characterized by the accumulation of lymphatic fluid called chyle in the pleural space, which is the space between the lungs and the chest wall. Chyle is a milky-white fluid that contains nutrients, electrolytes, and immune cells, and it is normally transported through the thoracic duct to the bloodstream.
Chylothorax can occur due to various reasons, such as trauma, surgery, tumors, or congenital abnormalities that disrupt the normal flow of chyle. As a result, chyle leaks into the pleural space, causing symptoms such as cough, chest pain, difficulty breathing, and fever.
The diagnosis of chylothorax is usually made through imaging studies such as chest X-ray or CT scan, and confirmed by analyzing the fluid for the presence of chylomicrons, which are lipid particles found in chyle. The treatment options for chylothorax include dietary modifications, such as a low-fat diet with medium-chain triglycerides, chest tube drainage, and surgical interventions such as thoracic duct ligation or pleurodesis.
Lymphangioleiomyomatosis (LAM) is a rare, progressive lung disease that primarily affects women of childbearing age. It is characterized by the abnormal growth of smooth muscle cells in the airways, blood vessels, and lymphatic system of the lungs. These cells can form cysts and lesions that can obstruct the airways and cause lung function to decline over time.
LAM can also affect other organs, such as the kidneys, where it can cause angiomyolipomas (benign tumors composed of blood vessels, muscle cells, and fat). In some cases, LAM may be associated with tuberous sclerosis complex (TSC), a genetic disorder that causes benign tumors to grow in various organs of the body.
The exact cause of LAM is not fully understood, but it is believed to be related to mutations in the TSC1 or TSC2 genes, which regulate cell growth and division. There is currently no cure for LAM, but treatments such as lung transplantation and medications that suppress the growth of smooth muscle cells may help manage symptoms and slow disease progression.
An encyclopedia is a comprehensive reference work containing articles on various topics, usually arranged in alphabetical order. In the context of medicine, a medical encyclopedia is a collection of articles that provide information about a wide range of medical topics, including diseases and conditions, treatments, tests, procedures, and anatomy and physiology. Medical encyclopedias may be published in print or electronic formats and are often used as a starting point for researching medical topics. They can provide reliable and accurate information on medical subjects, making them useful resources for healthcare professionals, students, and patients alike. Some well-known examples of medical encyclopedias include the Merck Manual and the Stedman's Medical Dictionary.
The lymphatic system is a complex network of organs, tissues, vessels, and cells that work together to defend the body against infectious diseases and also play a crucial role in the immune system. It is made up of:
1. Lymphoid Organs: These include the spleen, thymus, lymph nodes, tonsils, adenoids, and Peyer's patches (in the intestines). They produce and mature immune cells.
2. Lymphatic Vessels: These are thin tubes that carry clear fluid called lymph towards the heart.
3. Lymph: This is a clear-to-white fluid that contains white blood cells, mainly lymphocytes, which help fight infections.
4. Other tissues and cells: These include bone marrow where immune cells are produced, and lymphocytes (T cells and B cells) which are types of white blood cells that help protect the body from infection and disease.
The primary function of the lymphatic system is to transport lymph throughout the body, collecting waste products, bacteria, viruses, and other foreign substances from the tissues, and filtering them out through the lymph nodes. The lymphatic system also helps in the absorption of fats and fat-soluble vitamins from food in the digestive tract.
lymphangiectasis
Lymphangiectasis, Intestinal | Profiles RNS
Congenital Lung Malformations: Background, History of the Procedure, Problem
Những ca chữa lành ở thể chất - Hội thân hữu Bruno Gröning
Lymphangiomatosis - Wikipedia
Advanced Search Results - Public Health Image Library(PHIL)
Collagen XVIII and fibronectin involvement in bullous scleroderma
Diagnostic Pathology Nonneoplastic Pediatrics, 2nd edition - Angelica R. Putnam - 1020 - ELSEVIER HEALTH SCIENCES -...
International Classification of Diseases - Diseases of the Circulatory System
Congenital Lung Malformations: Background, History of the Procedure, Problem
Namespace
Specific PHGKB|Rare Diseases PHGKB|PHGKB
Unscramble specialtiy | 537 words unscrambled from specialtiy
Archivio Foto - Histoweb
Lymphangiomyomatosis - wikidoc
Basset Fauve de Bretagne Temperament: Skill and love
cystic hygroma ultrasound 11 weeks
Hennekam lymphangiectasia-lymphedema syndrome 1 (Concept Id: C4012050) - MedGen - NCBI
A Short Note on Generalized Lymphatic Anomaly: A Lymphatic Disorder
Acquired vulvar lymphangioma circumscriptum Sobti A, Wee DA, Tan KB - Astrocyte
22q11 Deletion Syndrome | Harvard Catalyst Profiles | Harvard Catalyst
Cheapest Buy Ranitidine Price London, Cheap ranitidine mastercard buy
DeCS
Penyembuhan fisik - Paguyuban Bruno Gröning
Búsqueda | BVS Bolivia
tissue - Page 2 - Atlas of Science
emphysema - Atlas of Science
Lymphatic vessels4
- lymphangiectasis - n. dilatation of the lymphatic vessels, which is usually congenital and produces enlargement of various parts of the body (e.g. the leg in Milroy s disease). (en-academic.com)
- lymphangiectasis, lymphangiectasia - Dilation of the lymphatic vessels, the basic process that may result in the formation of a lymphangioma. (en-academic.com)
- Disorders characterized by emphysematous dilation of lymphatic vessels (lymphangiectasis) associated with inflammatory process are uncommon. (atlasofscience.org)
- PHENOTYPE: Mice homozygous for a knock-out allele exhibit impaired integrity of the heart, blood vessels and lymphatic vessels, resulting in hemopericardium, lung hemorrhage, lymphangiectasis, and chylous ascites, as well as embryonic and postnatal lethality. (utsouthwestern.edu)
Lymphangiectasia1
- на английски език: lymphangiectasia, lymphangiectasis. (arsmedica.bg)
Pulmonary2
- Therefore, this article discusses bronchogenic cyst, pulmonary agenesis and hypoplasia, polyalveolar lobe, alveolocapillary dysplasia, sequestration including arteriovenous malformation (AVM) and scimitar syndrome, pulmonary lymphangiectasis, congenital lobar emphysema (CLE), and cystic adenomatoid malformation (CAM) and other lung cysts. (medscape.com)
- Lymphangiomyomatosis must be differentiated from other diseases that cause similar clinical features, such as asthma , spontaneous pneumothorax , emphysema , interstitial pulmonary fibrosis , eosinophilic granuloma (EG), Birt-Hogg-Dube syndrome, lymphangiomas , pulmonary lymphangiectasis, and leiomyosarcoma . (wikidoc.org)
Thoracic1
- Protein deficiency, kidney diseases (nephrotic syndrome, chronic glomerulonephritis), heart failure, myxedema, gastrointestinal diseases (pancreatitis, Crohn's disease, chronic diarrhea), lymphostasis associated with compression of the thoracic lymphatic duct, lymphangiectasis and difficulty in lymph outflow from the abdominal cavity predispose to the development of ascites. (medic-journal.com)
Pulmonary lymphangiomatosis1
- Pediatric congenital interstitial lung diseases generally carry high risk for morbidly and mortality and include congenital alveolar capillary dysplasia with misalignment of pulmonary veins, congenital alveolar dysplasia, acinar dysplasia, congenital pulmonary lymphangiectasis, diffuse pulmonary lymphangiomatosis, neuroendocrine cell hyperplasia of infancy, pulmonary hemosiderosis, pulmonary alveolar proteinosis, and pulmonary interstitial glycogenosis. (nih.gov)
Congenital pulmonary1
- Congenital Pulmonary Lymphangiectasis. (kjlm.or.kr)
Fibrosis1
- 14. [Intestinal lymphangiectasis secondary to cicatricial fibrosis of mesenteric nodes: a nosologic entity? (nih.gov)